62/100B416.68
USD
0.61
(0.15%)
Market Closed
Last updated: · Delayed 15 min
BeiGene EPS (earnings per share) 2013–2026What is EPS (earnings per share)? EPS (earnings per share) is a company's net income divided by its number of shares: the profit that belongs to each share over a period.
BeiGene's diluted EPS in Q3 FY2026, the three months to 30 September 2026, was 3.25 USD, down 76.0% on the same quarter a year before. BeiGene's diluted earnings per share over the last twelve months were 62.01 USD, up 379.2% on the twelve months before. In fiscal year 2025 they were 2.53 USD, against a loss of 6.12 USD on the year before.
Last updated 12 Nov 2026 · Next report 25 Feb 2027
EPS
| Fiscal year | Period ending | EPS | Growth | EPS (basic) |
|---|---|---|---|---|
| TTM | 30 Sept 2026 | 62.01 | +379.21% | 64.74 |
| FY2025 | 31 Dec 2025 | 2.53 | — | 2.63 |
| FY2024 | 31 Dec 2024 | -6.12 | — | -6.12 |
| FY2023 | 31 Dec 2023 | -8.45 | — | -8.45 |
| FY2022 | 31 Dec 2022 | -19.37 | — | -19.37 |
| FY2021 | 31 Dec 2021 | -15.21 | — | -15.21 |
| FY2020 | 31 Dec 2020 | -19.11 | — | -19.11 |
| FY2019 | 31 Dec 2019 | -15.86 | — | -15.86 |
| FY2018 | 31 Dec 2018 | -12.09 | — | -12.09 |
| FY2017 | 31 Dec 2017 | -2.21 | — | -2.21 |
| FY2016 | 31 Dec 2016 | -3.90 | — | -3.90 |
| FY2015 | 31 Dec 2015 | -1.82 | — | -1.82 |
| FY2014 | 31 Dec 2014 | -0.35 | — | -0.35 |
| FY2013 | 31 Dec 2013 | -1.43 | — | -1.43 |
| Quarter | Period ending | EPS | Growth on a year before | EPS (basic) |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 3.25 | -75.96% | 3.38 |
| Q2 FY2026 | 30 Jun 2026 | 26.65 | +3,072.62% | 27.04 |
| Q1 FY2026 | 31 Mar 2026 | 25.35 | +253,400.00% | 26.65 |
| Q4 FY2025 | 31 Dec 2025 | 6.76 | — | 7.67 |
| Q3 FY2025 | 30 Sept 2025 | 13.52 | — | 14.69 |
| Q2 FY2025 | 30 Jun 2025 | 0.84 | — | 0.87 |
| Q1 FY2025 | 31 Mar 2025 | 0.01 | — | 0.01 |
| Q4 FY2024 | 31 Dec 2024 | -1.43 | — | -1.43 |
| Q3 FY2024 | 30 Sept 2024 | -1.16 | -159.49% | -1.16 |
| Q2 FY2024 | 30 Jun 2024 | -1.15 | — | -1.15 |
| Q1 FY2024 | 31 Mar 2024 | -2.47 | — | -2.47 |
| Q4 FY2023 | 31 Dec 2023 | -25.48 | — | -25.48 |
| Q3 FY2023 | 30 Sept 2023 | 1.95 | — | 2.08 |
| Q2 FY2023 | 30 Jun 2023 | -3.64 | — | -3.64 |
| Q1 FY2023 | 31 Mar 2023 | -3.38 | — | -3.38 |
| Q4 FY2022 | 31 Dec 2022 | -30.55 | — | -30.55 |
| Q3 FY2022 | 30 Sept 2022 | -5.33 | — | -5.33 |
| Q2 FY2022 | 30 Jun 2022 | -5.59 | — | -5.59 |
| Q1 FY2022 | 31 Mar 2022 | -4.29 | -760.00% | -4.29 |
| Q4 FY2021 | 31 Dec 2021 | -6.11 | — | -6.11 |
| Q3 FY2021 | 30 Sept 2021 | -4.42 | — | -4.42 |
| Q2 FY2021 | 30 Jun 2021 | -5.20 | — | -5.20 |
| Q1 FY2021 | 31 Mar 2021 | 0.65 | — | 0.78 |
| Q4 FY2020 | 31 Dec 2020 | -5.20 | — | -5.20 |
| Q3 FY2020 | 30 Sept 2020 | -4.81 | — | -4.81 |
| Q2 FY2020 | 30 Jun 2020 | -4.29 | — | -4.29 |
| Q1 FY2020 | 31 Mar 2020 | -4.68 | — | -4.68 |
| Q4 FY2019 | 31 Dec 2019 | -6.37 | — | -6.37 |
| Q3 FY2019 | 30 Sept 2019 | -5.07 | — | -5.07 |
| Q2 FY2019 | 30 Jun 2019 | -1.43 | — | -1.43 |
| Q1 FY2019 | 31 Mar 2019 | -2.86 | — | -2.86 |
| Q4 FY2018 | 31 Dec 2018 | -4.55 | — | -4.55 |
| Q3 FY2018 | 30 Sept 2018 | -2.47 | -195.00% | -2.47 |
| Q2 FY2018 | 30 Jun 2018 | -2.86 | — | -2.86 |
| Q1 FY2018 | 31 Mar 2018 | -2.08 | — | -2.08 |
| Q4 FY2017 | 31 Dec 2017 | -2.21 | — | -2.21 |
| Q3 FY2017 | 30 Sept 2017 | 2.60 | — | 2.73 |
| Q2 FY2017 | 30 Jun 2017 | -1.56 | — | -1.56 |
| Q1 FY2017 | 31 Mar 2017 | -1.27 | — | -1.27 |
| Q4 FY2016 | 31 Dec 2016 | -0.95 | — | -0.95 |
| Q3 FY2016 | 30 Sept 2016 | -1.08 | — | -1.08 |
| Q2 FY2016 | 30 Jun 2016 | -0.73 | — | -0.73 |
| Q1 FY2016 | 31 Mar 2016 | -0.68 | — | -0.68 |
| Q4 FY2015 | 31 Dec 2015 | -0.86 | — | -0.86 |
| Q3 FY2015 | 30 Sept 2015 | -0.26 | — | -0.26 |
| Q2 FY2015 | 30 Jun 2015 | -0.11 | — | -0.11 |
| Q1 FY2015 | 31 Mar 2015 | -0.19 | — | -0.19 |
| Q4 FY2014 | 31 Dec 2014 | -0.07 | — | -0.07 |
| Q3 FY2014 | 30 Sept 2014 | -0.18 | — | -0.18 |
| Q2 FY2014 | 30 Jun 2014 | -4.29 | — | -4.29 |
| Q1 FY2014 | 31 Mar 2014 | -4.29 | — | -4.29 |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
See also:Revenue,Net income,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Income statement
Common questions about BeiGene's EPS
Source: Financial Modeling Prep